Skip to main content

Advertisement

SpringerLink
Log in

Irreversible cardiac changes after dexamethasone treatment for bronchopulmonary dysplasia

  • Letter to the Editor
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bensky AS, Kothadia JM, Covitz W (1996) Cardiac effects of dexamethasone in very low birth weight infants. Pediatrics 97:818–821

    PubMed  CAS  Google Scholar 

  2. Boeuf B, Maragnes P, Belzic I, et al (1997) Myocardiopathie hypertrophique induite par les glucocorticoïdes chez le prematuré: à propos de quatre cas. Arch Pédiatr 4:152–157

    Article  PubMed  CAS  Google Scholar 

  3. Brozanski BS, Jones JG, Gilmour CH, et al (1995) Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant. J Pediatr 126:769–776

    Article  PubMed  CAS  Google Scholar 

  4. Gill AW, Warner G, Bull L (1996) Iatrogenic neonatal hypertrophic cardiomyopathy. Pediatr Cardiol 17:335–339

    Article  PubMed  CAS  Google Scholar 

  5. Papile LA, Tyson JE, Stoll BJ, et al (1998) A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med 338:1112–1118

    Article  PubMed  CAS  Google Scholar 

  6. Tsukahara H, Watanabe Y, Ysutomi M, et al (1999) Early (4–7 days of age) dexamethasone therapy for prevention of chronic lung disease in preterm infants. Biol Neonate 76:283–290

    Article  PubMed  CAS  Google Scholar 

  7. Walther FJ, Siassi B, King J, Wu PYK (1986) Echocardiographic measurements in normal preterm and term neonates. Acta Paediatr Scand 75:563–568

    Article  PubMed  CAS  Google Scholar 

  8. Werner JC, Sicard RE, Hansen TWR, et al. (1992) Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr 120:286–291

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Friedrich-Schiller-University of Jena, Kochstraße 2, 07740, Jena, Germany

    F.-T. Riede

  2. Department of Pathology, Friedrich-Schiller-University of Jena, Ziegelminhlenweg, 07743, Jena, Germany

    E. Schulze

  3. Department of Pediatrics, Friedrich-Schiller-University of Jena, Kochstraße 2, 07740, Jena, Germany

    L. Vogt & D. Schramm

Authors
  1. F.-T. Riede
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Schulze
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Vogt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Schramm
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riede, FT., Schulze, E., Vogt, L. et al. Irreversible cardiac changes after dexamethasone treatment for bronchopulmonary dysplasia. Pediatr Cardiol 22, 363–364 (2001). https://doi.org/10.1007/s002460010249

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002460010249

Keywords

Search

Navigation